What is BLFY's health score?

Blue Foundry Bancorp (BLFY) has a TradeApes health score of 49 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is BLFY's estimated fair value?

Based on our 5-year discounted cash flow model, Blue Foundry Bancorp's estimated fair value is $13.97 per share, representing a 5.5% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is BLFY undervalued or overvalued?

Our model currently rates BLFY as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for BLFY... Refresh in a moment for the full analysis.

Blue Foundry Bancorp (BLFY)

Financials Fair Value low mixed

$13.24

Updated: 2026-06-06

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

65 Healthy

Risk

80 Strong

Est. Fair Value $13.97

DCF Upside +5.5%

Sector Rank #1334 of 6387

Key Findings

+ Active buybacks — share count declining, capital returned to owners

Unlock Full Report →

− FCF deteriorating — free cash flow down more than 25% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.